Fate Therapeutics (FATE) Interest Coverage Ratio (2012 - 2026)
Fate Therapeutics (FATE) posted Interest Coverage Ratio of 0.28 for Q1 2026, up 64.85% on a QoQ basis from 0.81 in Q3 2025, and up 10.9% year-over-year from 0.26 in Q1 2025.
Fate Therapeutics (FATE) Interest Coverage Ratio (2012 - 2026) Analysis & Trends
Fate Therapeutics' Interest Coverage Ratio history runs 15 years deep, the most recent figure standing at 0.28 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 10.9% year-over-year to 0.28 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.2 (up 22.49% YoY) and the FY2025 annual result came in at 0.38, up 34.45% from the prior year.
- Interest Coverage Ratio was 0.28 for Q1 2026 at Fate Therapeutics, up from 0.81 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.15 in Q4 2023 and bottomed at 4.65 in Q1 2022.
- A 5-year average of 0.93 and a median of 0.39 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio surged 90.7% — and 2025, when it plunged 1068.8%.
- Fate Therapeutics' Interest Coverage Ratio stood at 0.22 in 2022, then jumped by 31.76% to 0.15 in 2023, then declined by 14.92% to 0.17 in 2024, then slumped by 372.22% to 0.81 in 2025, then jumped by 64.85% to 0.28 in 2026.
- Business Quant data shows FATE's Interest Coverage Ratio at 0.28 in Q1 2026, 0.81 in Q3 2025, and 3.39 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Fate Therapeutics | 288.82 Mn | 288.82 Mn | - | -0.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.28 |
| Sep 30, 2025 | -0.81 |
| Jun 30, 2025 | -3.39 |
| Mar 31, 2025 | -0.32 |
| Dec 31, 2024 | -0.17 |
| Sep 30, 2024 | -0.34 |
| Jun 30, 2024 | -0.29 |
| Mar 31, 2024 | -0.89 |
| Dec 31, 2023 | -0.15 |
| Sep 30, 2023 | -0.31 |
| Jun 30, 2023 | -0.98 |
| Mar 31, 2023 | -0.43 |
| Dec 31, 2022 | -0.22 |
| Sep 30, 2022 | -1.22 |
| Jun 30, 2022 | -0.45 |
| Mar 31, 2022 | -4.65 |
| Dec 31, 2021 | -0.31 |
| Sep 30, 2021 | -0.29 |
| Jun 30, 2021 | -0.58 |
| Mar 31, 2021 | -0.56 |